-
Nov 4, 2013, 13:00 PM
by
Michael Croft
Bio-IT World | The past few weeks tranSMART has launched its membership program and announced a joint cloud computing initiative with BT. It’s a busy season for non-profit.
Full story
-
Nov 1, 2013, 13:00 PM
by
Michael Croft
Bio-IT World News Brief | Illumina’s verifi prenatal test will be offered to pregnant women in California through the state’s Prenatal Screening Program. Beginning today, all pregnant women in California at increased risk of carrying a fetus with trisomy 21 (Down syndrome) or trisomy 18 (Edwards syndrome), or who have had an ultrasound showing a large nuchal translucency, will have the option of receiving a non-invasive prenatal test.
Full story
-
Nov 1, 2013, 12:00 PM
by
Michael Croft
Oak Ridge Today | The University of Tennessee, Knoxville, (UT) has received a grant from Intel to develop computer codes to enable personalized medicine. The funding will open an Intel Parallel Computing Center at the Joint Institute for Computational Sciences, or JICS, at UT and Oak Ridge National Laboratory.
Full story
-
Nov 1, 2013, 08:30 AM
by
Michael Croft
Bio-IT World | With the rapid expansion of BaseSpace over the past two years, Illumina has been betting on the cloud as a future hub of cutting-edge genetic research. Now, new moves to encourage app developers to move into BaseSpace, along with the acquisition of NextBio, are expanding the range and power of the company's cloud-based analytics.
Full story
-
Oct 31, 2013, 10:50 AM
by
Michael Croft
MassGenomics | Dan Koboldt, who attended ASHG last week to discuss his work identifying pathogenic variants in families, shares his impressions from the meeting.
Full story
-
Oct 31, 2013, 08:00 AM
by
Michael Croft
Opiniomics Blog | Mick Watson is reporting on ICG8 from Shenzhen when he has the internet access, and he says Genia presented their single molecule sequencer. The instrument will cost less than $1000 and will be able to sequence human genomes for less than $100.
Full story
-
Oct 30, 2013, 08:30 AM
by
Michael Croft
Bio-IT World | The International Consortium for Human Phenotype Terminologies has announced an agreement between the major players in rare genetic disease research to use a fixed set of terms for human phenotypes, allowing computers to make rapid comparisons of patients and disease presentations across far-flung databases.
Full story
-
Oct 29, 2013, 14:00 PM
by
Michael Croft
Bio-IT World | The 2014 Bio-IT World Best Practices competition has released its call for entries. The advanced deadline for entry is February 10, 2014; the early deadline is December 16, 2013.
Full story
-
Oct 29, 2013, 11:00 AM
by
Michael Croft
NPR | The Titan supercomputer at Oak Ridge National Laboratory is no longer the number one supercomputer in the world. On its own, a shift in the supercomputing rankings is not surprising. But Thom Mason, director of Oak Ridge, is afraid America may soon slip permanently behind.
Full story
-
Oct 28, 2013, 15:15 PM
by
Michael Croft
Bio-IT World | The American Society of Human Genetics held its annual meeting in Boston last week, bringing together thousands of genetics professionals from around the world. Here's what you might have missed.
Full story
-
Oct 28, 2013, 13:00 PM
by
Michael Croft
Genomes Unzipped | Last year a paper was published claiming a simple genetic test could predict autism risk from birth. Many felt that the paper illustrated the pitfalls of pursuing genetic risk prediction.
Full story
-
Oct 28, 2013, 11:00 AM
by
Michael Croft
Bio-IT World News Brief | Illumina today announced it has signed a definitive agreement to acquire Santa Clara-based NextBio. NextBio's powerful big-data platforms aggregate and analyze large quantities of phenotypic and genomic data for research and clinical applications.
Full story
-
Oct 24, 2013, 15:00 PM
by
Michael Croft
Bio-IT World | deCODE genetics’ genomics platform has new life as NextCODE Health. The private company announced it launch yesterday with an exclusive license deCODE’s platform, a leadership team of deCODE alumni, and $15 million in venture financing.
Full story
-
Oct 23, 2013, 14:00 PM
by
Michael Croft
Xconomy | Open source and open systems are experiencing a "moment in the sun" in drug discovery says data commons advocate John Wilbanks.
Full story
-
Oct 23, 2013, 14:00 PM
by
Michael Croft
Forbes | With big pharma cutting R&D budgets, universities will need to step up. The Academic Drug Discovery Consortium (ADDC) hopes to facilitate just that.
Full story
-
Oct 23, 2013, 09:00 AM
by
Michael Croft
Bio-IT World | The latest challenge from the sbv IMPROVER project has launched. The Network Verification Challenge opened last week for submissions from the global scientific community.
Full story
-
Oct 22, 2013, 14:00 PM
by
Michael Croft
Bio-IT World | Bina Technologies has announced the general availability of its all-new RNA-Seq analysis capabilities. This new application delivers fast, accurate and scalable analysis of RNA-Seq datasets on top of the company’s Bina Genomic Analysis Platform.
Full story
-
Oct 22, 2013, 08:00 AM
by
Michael Croft
Bio-IT World | There are plenty of plaudits for organizations in the life sciences that change the industry’s conceptions of what is possible, but one purpose of the Bio-IT World Best Practices Awards is to highlight those who refine those achievements until the merely possible becomes truly practical. That is why Bio-IT World was pleased to award an honorable mention at the 2013 Best Practices Awards to TeselaGen Biotechnology, a startup that spun out from the Berkeley Lab’s Joint BioEnergy Institute (JBEI) in 2011, and Amgen for the development of TeselaGen: j5, an automated platform for designing DNA assembly protocols.
Full story
-
Oct 21, 2013, 15:00 PM
by
Michael Croft
Bio-IT World | The Broad Institute today announced that it has passed Massachusetts state inspection, and can begin processing clinical samples as a CLIA-certified lab.
Full story
-
Oct 21, 2013, 13:00 PM
by
Michael Croft
Bio-IT World News Brief | Foundation Medicine has announced findings from a 24-month, multi-institution collaboration demonstrating the analytic validation of its FoundationOne cancer genomics assay. The results were published in the online edition of Nature Biotechnology.
Full story